Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:AGCO
NYSE:AGCOMachinery

AGCO (AGCO) Is Up 15.6% After Profit Rebound And 2026 Outlook With New Tractor Innovations

In early February 2026, AGCO Corporation reported fourth-quarter 2025 results with quarterly sales of US$2,920.2 million, a return to net profitability, and full-year 2025 sales of US$10,082 million alongside earnings per share from continuing operations of US$9.75. The company also issued 2026 guidance targeting net sales of US$10.4 billion to US$10.7 billion and earnings per share of about US$5.50 to US$6.00, while showcasing new Fendt and Massey Ferguson innovations such as the Fendt e100...
XTRA:DHER
XTRA:DHERHospitality

Assessing Delivery Hero (XTRA:DHER) Valuation After Cost Cuts And Exit From Underperforming Regions

Delivery Hero (XTRA:DHER) is back in focus after management launched a broad strategy review, streamlined costs, and exited underperforming regions. These moves are reshaping how investors look at the food delivery group. See our latest analysis for Delivery Hero. The recent strategy review and cost focus comes after a sharp 7 day share price return of negative 13.89% and a 1 year total shareholder return of negative 16.96%, despite a 90 day share price return of 26.67%. This suggests that...
NYSE:WLK
NYSE:WLKChemicals

A Look At Westlake (WLK) Valuation After Mixed Analyst Calls And Mizuho Downgrade

Why recent analyst moves matter for Westlake stock Mizuho’s decision to shift Westlake (WLK) from an Outperform rating to Neutral, while other firms keep buy calls in place, has put fresh attention on what current prices already reflect. See our latest analysis for Westlake. The recent analyst debate comes on the heels of strong short term momentum, with a 4.08% 1 day share price return and a 51.19% 90 day share price return, contrasting with a 1 year total shareholder return decline of...
SEHK:1928
SEHK:1928Hospitality

Does Sands China (SEHK:1928)’s Dividend Timing Hint At A New Macao Risk-Reward Trade-Off?

In early February 2026, Sands China set a board meeting for February 13, 2026 to approve its 2025 annual results and consider a potential final dividend, while Las Vegas Sands filed its 2025 Form 10-K with segment data on Macao operations. Together, these disclosures spotlight Sands China’s profit distribution approach and underline the regulatory and market uncertainties facing its Macao gaming business. With this backdrop, we’ll examine how the upcoming dividend decision and risk...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Pricing Reflect Recent 1 Year Rally And Cash Flow Outlook

If you have been wondering whether Roche Holding's current share price really lines up with its underlying worth, this article walks you through the key numbers that matter. Over the short term the stock has been relatively steady, with a 0.2% decline over the last 7 days. The 30 day, year to date and 1 year returns sit at 3.8%, 8.7% and 25.8% respectively, and the 3 year and 5 year figures are 41.4% and 33.3%. Recent coverage of Roche has focused on its position as a global healthcare group...
NasdaqGS:WERN
NasdaqGS:WERNTransportation

Werner Enterprises (WERN) Valuation Check After Quarterly Loss And Freight Market Weakness

Werner Enterprises (WERN) stock is in focus after the company reported a quarterly loss, missed revenue and earnings expectations, and highlighted pressure from a soft freight market and higher operating costs. See our latest analysis for Werner Enterprises. The weak quarter triggered an 8.21% one day share price decline and a 4.45% seven day share price return, although the 90 day share price return of 40.05% and 1 year total shareholder return of 2.61% point to momentum that has cooled...
NYSE:NUE
NYSE:NUEMetals and Mining

Nucor (NUE) Is Up 6.6% After Earnings Beat And Strong 2026 Outlook Has The Bull Case Changed?

Nucor Corporation has reported its fourth-quarter and full-year 2025 results, with annual sales rising to US$32.49 billion while net income eased to US$1.74 billion, and quarterly earnings improving year over year. Alongside completing a multiyear US$3.59 billion share repurchase program, Nucor issued guidance pointing to higher first-quarter 2026 earnings across all three operating segments. We’ll now examine how Nucor’s expectation of higher first-quarter 2026 earnings across all segments...
NasdaqGS:RVMD
NasdaqGS:RVMDBiotechs

First-in-Human RMC-5127 Trial Could Be A Game Changer For Revolution Medicines (RVMD)

Revolution Medicines recently dosed the first patient in its first-in-human trial of RMC-5127, an open-label study assessing safety, tolerability, pharmacokinetics and early antitumor activity in RAS G12V-mutated solid tumors that have progressed after standard therapies. This marks a key pipeline milestone targeting RAS G12V, the second most common driver of RAS-addicted cancers in the US, affecting roughly 48,000 patients annually. We will now examine how initiating first-in-human testing...